{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:46:48Z","timestamp":1791917208000,"version":"4.3.4"},"reference-count":69,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.cpet.2018.12.004","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T06:36:52Z","timestamp":1549003012000},"page":"223-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["PET\/CT Evaluation of Cardiac Sarcoidosis"],"prefix":"10.1016","volume":"14","author":[{"given":"John P.","family":"Bois","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Muser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panithaya","family":"Chareonthaitawee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cpet.2018.12.004_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1513\/AnnalsATS.201508-568BC","article-title":"Epidemiology of sarcoidosis in a prospective cohort study of U.S. women","volume":"13","author":"Dumas","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"10.1016\/j.cpet.2018.12.004_bib2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.rmed.2012.02.007","article-title":"Unexpectedly high prevalence of sarcoidosis in a representative U.S. Metropolitan population","volume":"106","author":"Erdal","year":"2012","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.cpet.2018.12.004_bib3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.cpet.2018.12.004_bib4","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cpet.2018.12.004_bib5","first-page":"167","article-title":"Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations","volume":"119","author":"Perry","year":"1995","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.cpet.2018.12.004_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/hrt.2005.080481","article-title":"Cardiac sarcoidosis","volume":"92","author":"Doughan","year":"2006","journal-title":"Heart"},{"issue":"32","key":"10.1016\/j.cpet.2018.12.004_bib7","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1093\/eurheartj\/ehu086","article-title":"Multiparametric assessment of myocarditis using simultaneous positron emission tomography\/magnetic resonance imaging","volume":"35","author":"Nensa","year":"2014","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.cpet.2018.12.004_bib8","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2018.12.004_bib9","doi-asserted-by":"crossref","DOI":"10.17996\/anc.17-00029","article-title":"New guidelines for diagnosis of cardiac sarcoidosis in Japan","author":"Yoshinaga","year":"2017","journal-title":"Annals of Nuclear Cardiology"},{"issue":"7","key":"10.1016\/j.cpet.2018.12.004_bib10","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.cpet.2018.12.004_bib11","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s12350-016-0477-4","article-title":"Continuing evolution in preparation protocols for 18FDG PET assessment of inflammatory or malignant myocardial disease","volume":"24","author":"Bois","year":"2017","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"3","key":"10.1016\/j.cpet.2018.12.004_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0033-0620(89)90027-3","article-title":"Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography","volume":"32","author":"Camici","year":"1989","journal-title":"Prog Cardiovasc Dis"},{"issue":"5","key":"10.1016\/j.cpet.2018.12.004_bib13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.HYP.11.5.416","article-title":"Effects of moderate hypertension on cardiac function and metabolism in the rabbit","volume":"11","author":"Taegtmeyer","year":"1988","journal-title":"Hypertension"},{"key":"10.1016\/j.cpet.2018.12.004_bib14","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1148\/rg.315115003","article-title":"How to differentiate benign versus malignanct cardiac and paracardiac 18F FDG uptake at oncollogic PET\/CT","volume":"31","author":"Maurer","year":"2011","journal-title":"Radiographics"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2018.12.004_bib15","doi-asserted-by":"crossref","first-page":"80S","DOI":"10.2967\/jnumed.109.068205","article-title":"Tracing cardiac metabolism in\u00a0vivo: one substrate at a time","volume":"51","author":"Taegtmeyer","year":"2010","journal-title":"J\u00a0Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2018.12.004_bib16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12350-015-0226-0","volume":"23","author":"Manabe","year":"2016","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"6","key":"10.1016\/j.cpet.2018.12.004_bib17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/0284185115600916","article-title":"Administration of unfractionated heparin with prolonged fasting could reduce physiological 18F-fluorodeoxyglucose uptake in the heart","volume":"57","author":"Masuda","year":"2016","journal-title":"Acta Radiol"},{"issue":"1","key":"10.1016\/j.cpet.2018.12.004_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2191-219X-4-1","article-title":"Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis","volume":"4","author":"Morooka","year":"2014","journal-title":"EJNMMI Res"},{"issue":"5","key":"10.1016\/j.cpet.2018.12.004_bib19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s12350-009-9110-0","article-title":"Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis","volume":"16","author":"Langah","year":"2009","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"10","key":"10.1016\/j.cpet.2018.12.004_bib20","first-page":"228","article-title":"Improved patient education facilitates adherence to preoperative fasting guidelines","volume":"24","author":"Kyrtatos","year":"2014","journal-title":"J\u00a0Perioper Pract"},{"key":"10.1016\/j.cpet.2018.12.004_bib21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00003643-201306001-00507","article-title":"Evaluation of adherence to recommended fasting guidelines in pediatric surgery in a teaching hospital in the UKL 19AP3-3","volume":"30","author":"Nadella","year":"2013","journal-title":"Eur J Anaesthesiol"},{"issue":"5","key":"10.1016\/j.cpet.2018.12.004_bib22","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s12350-011-9422-8","article-title":"Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake","volume":"18","author":"Harisankar","year":"2011","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"2","key":"10.1016\/j.cpet.2018.12.004_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI112820","article-title":"Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans","volume":"79","author":"Wisneski","year":"1987","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.cpet.2018.12.004_bib24","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1007\/s12350-013-9798-8","article-title":"Complete somatostatin-induced insulin suppression combined with heparin loading does not significantly suppress myocardial 18F-FDG uptake in patients with suspected cardiac sarcoidosis","volume":"20","author":"Gormsen","year":"2013","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"5","key":"10.1016\/j.cpet.2018.12.004_bib25","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s12350-014-9921-5","article-title":"Quantifying myocardial inflammation using F18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis","volume":"21","author":"Waller","year":"2014","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"1","key":"10.1016\/j.cpet.2018.12.004_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-016-0502-7","article-title":"Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation","volume":"24","author":"Osborne","year":"2017","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.cpet.2018.12.004_bib27","article-title":"Patient page-sarcoidosis imaging","author":"Bois","year":"2017","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"2","key":"10.1016\/j.cpet.2018.12.004_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12350-015-0252-y","article-title":"Optimizing radionuclide imaging in the assessment of cardiac sarcoidosis","volume":"23","author":"Bois","year":"2016","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"4","key":"10.1016\/j.cpet.2018.12.004_bib29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12149-014-0806-0","article-title":"Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations","volume":"28","author":"Ishida","year":"2014","journal-title":"Ann Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2018.12.004_bib30","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s12350-016-0443-1","article-title":"Evaluation of a low-carbohydrate diet-based preparation protocol without fasting for cardiac PET\/MR imaging","volume":"24","author":"Nensa","year":"2017","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"5","key":"10.1016\/j.cpet.2018.12.004_bib31","first-page":"426","article-title":"The value of (68)Ga-DOTATATE PET\/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature","volume":"4","author":"Mojtahedi","year":"2014","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.cpet.2018.12.004_bib32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13550-016-0207-6","article-title":"A\u00a0dual tracer (68)Ga-DOTANOC PET\/CT and (18)F-FDG PET\/CT pilot study for detection of cardiac sarcoidosis","volume":"6","author":"Gormsen","year":"2016","journal-title":"EJNMMI Res"},{"issue":"47","key":"10.1016\/j.cpet.2018.12.004_bib33","doi-asserted-by":"crossref","first-page":"77807","DOI":"10.18632\/oncotarget.12799","article-title":"Somatostatin receptor based PET\/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI","volume":"7","author":"Lapa","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.cpet.2018.12.004_bib34","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","article-title":"ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures","volume":"23","author":"Dilsizian","year":"2016","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"12","key":"10.1016\/j.cpet.2018.12.004_bib35","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.2967\/jnumed.111.092726","article-title":"Performance measurements of the Siemens mMR integrated whole-body PET\/MR scanner","volume":"52","author":"Delso","year":"2011","journal-title":"J\u00a0Nucl Med"},{"issue":"7","key":"10.1016\/j.cpet.2018.12.004_bib36","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2967\/jnumed.107.039792","article-title":"Frequent diagnostic errors in cardiac PET\/CT due to misregistration of CT attenuation and emission PET images: a definitive analysis of causes, consequences, and corrections","volume":"48","author":"Gould","year":"2007","journal-title":"J\u00a0Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2018.12.004_bib37","doi-asserted-by":"crossref","first-page":"e000867","DOI":"10.1161\/CIRCIMAGING.113.000867","article-title":"Evaluation of known or suspected cardiac sarcoidosis","volume":"9","author":"Blankstein","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"12","key":"10.1016\/j.cpet.2018.12.004_bib38","first-page":"1989","article-title":"Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis","volume":"45","author":"Okumura","year":"2004","journal-title":"J\u00a0Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2018.12.004_bib39","first-page":"436","article-title":"Do implanted pacemaker leads and ICD leads cause metal-related artifact in cardiac PET\/CT?","volume":"46","author":"DiFilippo","year":"2005","journal-title":"J\u00a0Nucl Med"},{"issue":"12","key":"10.1016\/j.cpet.2018.12.004_bib40","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jcmg.2010.09.015","article-title":"Heterogenous myocardial FDG uptake and the disease activity in cardiac sarcoidosis","volume":"3","author":"Tahara","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.cpet.2018.12.004_bib41","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jcmg.2008.07.001","article-title":"Extracardiac findings: what is a cardiologist to do?","volume":"1","author":"Douglas","year":"2008","journal-title":"JACC Cardiovasc Imaging"},{"issue":"9","key":"10.1016\/j.cpet.2018.12.004_bib42","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/RLU.0b013e3181ea3613","article-title":"Incidental detection of a pulmonary adenocarcinoma on low-dose computed tomography used for attenuation correction in myocardial perfusion imaging with SPECT","volume":"35","author":"Husmann","year":"2010","journal-title":"Clin Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2018.12.004_bib43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/1450-1147.144822","article-title":"Looking outside the \u201ccardiac\u201d box: incidental detection of a metastatic lung tumor on cardiac position emission tomography\/computed tomography","volume":"13","author":"Shawgi","year":"2014","journal-title":"World J Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2018.12.004_bib44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J\u00a0Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2018.12.004_bib45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.cpet.2018.12.004_bib46","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"issue":"21","key":"10.1016\/j.cpet.2018.12.004_bib47","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in 18F-fluorodeoxyglucose uptake in serial cardiac positrom emission tomography is associated with improved left ventricualr ejection fraction in patients with cardiac sarcoidosis","volume":"2014","author":"Osborne","year":"2014","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"8","key":"10.1016\/j.cpet.2018.12.004_bib48","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s00259-018-4001-8","article-title":"Prognostic role of serial quantitative evaluation of (18)F-fluorodeoxyglucose uptake by PET\/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia","volume":"45","author":"Muser","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2018.12.004_bib49","volume":"vol. 4","author":"Muser","year":"2017"},{"issue":"8","key":"10.1016\/j.cpet.2018.12.004_bib50","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004333","article-title":"Long-term outcomes of catheter ablation of ventricular tachycardia in patients with cardiac sarcoidosis","volume":"9","author":"Muser","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"10.1016\/j.cpet.2018.12.004_bib51","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12350-016-0490-7","article-title":"The response of FDG uptake to immunosuppressive treatment on FDG PET\/CT imaging for cardiac sarcoidosis","volume":"24","author":"Ahmadian","year":"2017","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"5","key":"10.1016\/j.cpet.2018.12.004_bib52","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/0002-8703(92)90431-T","article-title":"Thallium-201 and gallium 67 single photon emission computed tomographic imaging in cardiac sarcoidosis","volume":"124","author":"Tawarahara","year":"1992","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpet.2018.12.004_bib53","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1749-6632.1976.tb47058.x","article-title":"Clinicopathological study of fatal myocardial sarcoidosis","volume":"278","author":"Matsui","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cpet.2018.12.004_bib54","volume":"vol. 32","author":"Man\u00e1","year":"2005"},{"issue":"6","key":"10.1016\/j.cpet.2018.12.004_bib55","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00003072-199406000-00012","article-title":"Myocardial involvement in patients with sarcoidosis. An analysis of 75 patients","volume":"19","author":"Hirose","year":"1994","journal-title":"Clin Nucl Med"},{"issue":"6","key":"10.1016\/j.cpet.2018.12.004_bib56","first-page":"466","article-title":"Cutaneous sarcoidosis with cardiac involvement","volume":"9","author":"Okamoto","year":"1999","journal-title":"Eur J Dermatol"},{"issue":"2","key":"10.1016\/j.cpet.2018.12.004_bib57","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1378\/chest.107.2.330","article-title":"Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis","volume":"107","author":"Okayama","year":"1995","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.cpet.2018.12.004_bib58","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1378\/chest.126.4.1372","article-title":"Usefulness of dual 67Ga and 99mTc-sestamibi single-photon-emission CT scanning in the diagnosis of cardiac sarcoidosis","volume":"126","author":"Nakazawa","year":"2004","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.cpet.2018.12.004_bib59","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MCP.0b013e3283480d36","article-title":"Molecular imaging in sarcoidosis","volume":"17","author":"Mana","year":"2011","journal-title":"Curr Opin Pulm Med"},{"issue":"19","key":"10.1016\/j.cpet.2018.12.004_bib60","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.jacc.2007.09.008","volume":"50","author":"Cooper","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.cpet.2018.12.004_bib61","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00259-007-0650-8","article-title":"Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis","volume":"35","author":"Ohira","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.cpet.2018.12.004_bib62","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF00050989","article-title":"Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations","volume":"10","author":"Sekiguchi","year":"1996","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"10.1016\/j.cpet.2018.12.004_bib63","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1378\/chest.122.6.1895","article-title":"Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study","volume":"122","author":"Vignaux","year":"2002","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.cpet.2018.12.004_bib64","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jacc.2009.02.069","article-title":"Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve","volume":"54","author":"Herzog","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.cpet.2018.12.004_bib65","first-page":"1193","article-title":"Reproducibility of measurements of regional myocardial blood flow in a model of coronary artery disease: comparison of H215O and 13NH3 PET techniques","volume":"47","author":"Chareonthaitawee","year":"2006","journal-title":"J\u00a0Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2018.12.004_bib66","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2016.09.023","article-title":"Myocardial blood flow and inflammatory cardiac sarcoidosis","volume":"10","author":"Kruse","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.cpet.2018.12.004_bib67","first-page":"25","article-title":"Cardiovascular PET\/MRI: challenges and opportunities","volume":"34","author":"LaForest","year":"2016","journal-title":"Cardiol Clin"},{"issue":"22","key":"10.1016\/j.cpet.2018.12.004_bib68","doi-asserted-by":"crossref","first-page":"e639","DOI":"10.1161\/CIRCULATIONAHA.112.001217","article-title":"Active cardiac sarcoidosis: first clinical experience of simultaneous positron emission tomography\u2013magnetic resonance imaging for the diagnosis of cardiac disease","volume":"127","author":"White","year":"2013","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cpet.2018.12.004_bib69","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/mrm.1910380606","article-title":"Two-point Dixon technique for water-fat signal decomposition with B0 inhomogeneity correction","volume":"38","author":"Coombs","year":"1997","journal-title":"Magn Reson Med"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859818301354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859818301354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:05:29Z","timestamp":1761563129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859818301354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1556859818301354"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2018.12.004","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PET\/CT Evaluation of Cardiac Sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2018.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}